| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $0.962 (Beat by $0.182) |
| EPS GAAP Actual | $0.962 (Beat by $0.182) |
| Revenue Actual | $1.025B |
| Revenue Surprise | Beat by $1025M |
| Announce Date | 03/28/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.69 |
| EPS GAAP Estimate | $0.69 |
| Revenue Estimate | $1.225666667B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2028 | 2.11122 | 9.79 | 1.679 | 2.54344 | 2 |
| Mar 2028 | 3.8 | 5.44 | 3.64051 | 3.96639 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.97 | 0.97 | 1.025B | -23.02% | 1025M |
| FQ3 2025 (Sep 2025) | -0.28 | -0.28 | 0.856B | -26.05% | 856M |
| FQ2 2025 (Jun 2025) | 0.44 | 0.44 | 0.797B | -33.88% | 797M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 1.035B | -18.16% | 1035M |
| FQ4 2024 (Dec 2024) | -4.61 | -4.61 | 1.261B | -13.16% | 1261M |
| FQ3 2024 (Sep 2024) | 0.19 | 0.19 | 1.079B | -13.9% | 1079M |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 1.067B | -25.12% | 1067M |
| FQ1 2024 (Mar 2024) | -4.03 | -4.03 | 1.223B | 100% | 1223M |
FQ4 Announce Date
03/28/2026 (Pre-Market)
Consensus EPS Estimates
0.69
Consensus Revenue Estimates
1.225666667B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.3128 | -- | 0.30612 | 0.32275 | 7 |
| FQ4 2027 (Dec 2027) | 1.0425 | -- | 1.02025 | 1.07565 | 3 |
| FQ3 2027 (Sep 2027) | 0.5363 | -- | 0.52485 | 0.55335 | 6 |
| FQ2 2027 (Jun 2027) | 0.4435 | -- | 0.43403 | 0.4576 | 3 |
| FQ1 2027 (Mar 2027) | 0.5259 | -- | 0.50728 | 0.5883 | 2 |
| FQ4 2026 (Dec 2026) | 0.81882 | -18.46 | 0.80703 | 0.83005 | 2 |
| FQ3 2026 (Sep 2026) | 0.4585 | 161.07 | 0.44226 | 0.5129 | 2 |
| FQ2 2026 (Jun 2026) | 0.34735 | -26.67 | 0.33505 | 0.38856 | 2 |
| FQ1 2026 (Mar 2026) | 0.69 | -- | 0.69 | 0.69 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.85B | -- | 0.84B | 0.87B | 6 |
| FQ4 2027 (Dec 2027) | 1.07B | -- | 1.05B | 1.09B | 4 |
| FQ3 2027 (Sep 2027) | 0.9B | -- | 0.88B | 0.92B | 7 |
| FQ2 2027 (Jun 2027) | 0.83B | -- | 0.82B | 0.85B | 4 |
| FQ1 2027 (Mar 2027) | 1.11B | -- | 1.08B | 1.21B | 5 |
| FQ4 2026 (Dec 2026) | 1.02B | -0.09 | 1.01B | 1.03B | 3 |
| FQ3 2026 (Sep 2026) | 1.09B | 21.11 | 1.06B | 1.18B | 4 |
| FQ2 2026 (Jun 2026) | 1.05B | 23.84 | 1.02B | 1.14B | 7 |
| FQ1 2026 (Mar 2026) | 1.23B | 15.56 | 1.23B | 1.23B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.97 | 0.97 | 100% | |
| FQ3 2025 (Sep 2025) | -0.28 | -0.28 | 100% | |
| FQ2 2025 (Jun 2025) | 0.44 | 0.44 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Dec 2024) | -4.61 | -4.61 | 100% | |
| FQ3 2024 (Sep 2024) | 0.19 | 0.19 | 100% | |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 100% | |
| FQ1 2024 (Mar 2024) | -4.03 | -4.03 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $1.03B | $1025M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $0.86B | $856M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.8B | $797M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.04B | $1035M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.26B | $1261M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.08B | $1079M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.07B | $1067M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.22B | $1223M | 100% |